RANI
Rani TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RANI Profile
Rani Therapeutics Holdings, Inc.
A clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs
Pharmaceutical
04/06/2021
07/30/2021
NASDAQ Stock Exchange
105
12-31
Common stock
2051 Ringwood Avenue, San Jose, California 95131
--
Rani Therapeutics Holdings, Inc., was incorporated in Delaware on April 6, 2021. The company is a clinical-stage biotherapeutic company advancing technology to facilitate the development of oral biologics, which the company believes has the potential to transform medicine and improve treatment outcomes for patients. The company developed RaniPill capsules, the company's novel, proprietary and patented platform technology designed to replace subcutaneous or intravenous biological agents with oral administration.
